Natco Pharma informs about closure of trading window

30 Dec 2022 Evaluate
Natco Pharma has informed that the Trading Window for dealing in the securities of the Company would remain closed for the Directors, Designated Persons, their immediate relatives and all other connected persons covered in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time with effect from January 1, 2023 to till 48 hours after the declaration of the Financial Results of the Company for the quarter ending on December 31, 2022. The date of the Board Meeting for declaration of the financial results of the Company for the quarter ending on December 31, 2022 will be intimated in due course of time.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

1374.50 8.35 (0.61%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.